A
Andrew M. Goldsweig
Researcher at University of Nebraska Medical Center
Publications - 134
Citations - 1427
Andrew M. Goldsweig is an academic researcher from University of Nebraska Medical Center. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 13, co-authored 73 publications receiving 1011 citations. Previous affiliations of Andrew M. Goldsweig include Rhode Island Hospital & University of Nebraska Omaha.
Papers
More filters
Journal ArticleDOI
Activity-dependent neuroprotective protein: a novel gene essential for brain formation.
Albert Pinhasov,Shmuel Mandel,Arkady Torchinsky,Eliezer Giladi,Zipora Pittel,Andrew M. Goldsweig,Stephen J. Servoss,Douglas E. Brenneman,Illana Gozes +8 more
TL;DR: In this article, a mouse ADNP was shown to be expressed at the time of neural tube closure, detected at E7.5 and increased on E9.5, sustained throughout embryogenesis and regulated by VIP.
Journal ArticleDOI
Improved Outcomes Associated with the use of Shock Protocols: Updates from the National Cardiogenic Shock Initiative
Mir B Basir,Navin K. Kapur,Kirit Patel,Murad A Salam,Theodore Schreiber,Amir Kaki,Ivan Hanson,Steve Almany,Steve Timmis,Simon R. Dixon,Brian Kolski,Josh Todd,Shaun R. Senter,Steven P. Marso,David Lasorda,Charles Wilkins,Thomas LaLonde,Antonious Attallah,Timothy Larkin,Allison Dupont,J. Jeffrey Marshall,Nainesh Patel,Tjuan Overly,Michael Green,Behnam Tehrani,Alexander G. Truesdell,Rahul Sharma,Yasir N. Akhtar,Thomas McRae,Brian P. O'Neill,John Finley,Ayaz Rahman,Malcolm T. Foster,Raza Askari,Andrew M. Goldsweig,Scott Martin,Aditya Bharadwaj,Matheen A. Khuddus,Christopher Caputo,Denes Korpas,Ian Cawich,David McAllister,Nimrod Blank,M. Chadi Alraies,Ruth Fisher,Akshay Khandelwal,Khaldoon Alaswad,Alejandro Lemor,Tyrell Johnson,Michael Hacala,William W. O'Neill +50 more
TL;DR: The National Cardiogenic Shock Initiative is a single‐arm, prospective, multicenter study to assess outcomes associated with early mechanical circulatory support in patients presenting with acute myocardial infarction and cardiogenic shock treated with percutaneous coronary intervention.
Journal ArticleDOI
Iterative high-throughput polymorphism studies on acetaminophen and an experimentally derived structure for form III.
Matthew Peterson,Sherry L. Morissette,Chris McNulty,Andrew M. Goldsweig,Paul E. Shaw,Martin LeQuesne,Julie Monagle,Nicolas Encina,Joseph Marchionna,Alasdair Johnson,Javier Gonzalez-Zugasti,Anthony V. Lemmo,Stephen J. Ellis,Michael J. Cima,Orn Almarsson +14 more
TL;DR: Three crystal forms of acetaminophen were prepared and characterized using a newly developed high-throughput crystallization platform, CrystalMax, and one structure suggested has a bilayer motif, held together by O-H...O(H) hydrogen bonds, and helps explain the difficulty associated with preparing this form from solution.
Journal ArticleDOI
Thirty-Day Readmissions After Transcatheter Aortic Valve Replacement in the United States: Insights From the Nationwide Readmissions Database.
Dhaval Kolte,Sahil Khera,M. Rizwan Sardar,Neil Gheewala,Tanush Gupta,Saurav Chatterjee,Andrew M. Goldsweig,Wilbert S. Aronow,Gregg C. Fonarow,Deepak L. Bhatt,Adam Greenbaum,Paul C. Gordon,Barry L. Sharaf,J. Dawn Abbott +13 more
TL;DR: Thirty-day readmissions after TAVR are frequent and are related to baseline comorbidities, T AVR access site, and post-procedure complications, and awareness of these predictors can help identify and target high-risk patients for interventions to reduce readmissions and costs.
Journal ArticleDOI
Outcomes Following Urgent/Emergent Transcatheter Aortic Valve Replacement: Insights From the STS/ACC TVT Registry.
Dhaval Kolte,Sahil Khera,Sreekanth Vemulapalli,Dadi Dai,Stephan Heo,Andrew M. Goldsweig,Herbert D. Aronow,Sammy Elmariah,Ignacio Inglessis,Igor F. Palacios,Vinod H. Thourani,Barry L. Sharaf,Paul C. Gordon,J. Dawn Abbott +13 more
TL;DR: In patients undergoing urgent/emergent TAVR, non-femoral access and cardiopulmonary bypass were associated with increased risk, whereas use of balloon-expandable valve was associated with decreased risk of 30-day and 1-year mortality.